Wickes Group plc (FRA:0FD)
Germany · Delayed Price · Currency is EUR 2.520
0.00 (0.00%)
At close: Jul 31, 2025, 10:00 PM CET
Intra-Cellular Therapies Revenue
In the year 2024, Wickes Group had annual revenue of 1.54B GBP, down -0.97%. Wickes Group had revenue of 738.90M in the half year ending December 28, 2024, a decrease of -0.16%.
Revenue
1.54B GBP
Revenue Growth
-0.97%
P/S Ratio
0.33
Revenue / Employee
197.94K GBP
Employees
7,774
Market Cap
607.62M USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 28, 2024 | 1.54B | -15.00M | -0.97% |
| Dec 30, 2023 | 1.55B | -8.60M | -0.55% |
| Dec 31, 2022 | 1.56B | 27.50M | 1.79% |
| Jan 1, 2022 | 1.53B | 188.00M | 13.96% |
| Dec 26, 2020 | 1.35B | 54.50M | 4.22% |
| Dec 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 29, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 35.89B |
| Siemens Aktiengesellschaft | 77.82B |
| Deutsche Telekom AG | 120.25B |
| Allianz SE | 109.03B |
| Rheinmetall AG | 10.48B |
| Siemens Energy AG | 37.44B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.84B |
| Deutsche Bank Aktiengesellschaft | 30.07B |